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Abstract
B-cell activation factor belonging to the tumor necrosis factor family (BAFF) is a major contributor to survival of B
lymphocytes during development and maturation. A relationship between circulating BAFF levels and disease activity has
been reported in patients with the autoimmune disease Systemic Lupus Erythematosus (SLE). Clinical trials targeting BAFF
or its receptors are currently in progress. In order to further characterize a rabbit (Oryctolagus cuniculus) model of SLE, we
investigated the expression of BAFF and its receptors in non-inbred, pedigreed rabbits derived from breeding and selection
based on autoantibody responses. We immunized rabbits related to previous groups that developed autoantibodies and
inflammatory responses after immunizations with peptides synthesized on multiple antigen-branched polylysine
backbones. Blood and sera collected before immunization and after boosts were used for health monitoring, analyses of
serum autoantibody responses by ELISA and immunofluorescence. Peripheral blood mononuclear cells (PBMC) were studied
by flow cytometry and were the source of mRNA for quantitative PCR analyses. We hypothesized that BAFF mRNA
expression and serum BAFF levels measured indirectly through BAFF receptor binding might increase in autoantibody-
producing rabbits. Immunized rabbits developed elevated levels of leucocyte populations, anti-nuclear, anti-dsDNA and
other autoantibodies. BR3 mRNA levels in total PBMC decreased and BAFF levels remained low and unchanged in most
immunized rabbits. By flow cytometry, percentages of BAFF positive cells decreased. Percentages of transmembrane
activator and CAML interactor (TACI) decreased in most rabbits from all the immunized groups. The rabbit is an important
model for human autoimmune and infectious diseases, and a high quality draft rabbit genome assembly was recently
completed. Human disease models developed in non-inbred pedigreed animals are better able to reflect the complexities of
diseases such as SLE with familial patterns of inheritance. Although no consistent pattern of elevated expression of BAFF
mRNA or protein was found in the rabbits studied, the data collected and reported here build upon previous data to refine
understanding of a rabbit model of SLE.
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Introduction
Systemic Lupus Erythematosus (SLE) is a complex autoimmune
disease with considerable heterogeneity in clinical manifestations
and disease course. Although multiple immunologic abnormalities
contribute to the development of SLE, it is generally accepted that
B cells play key roles in disease pathogenesis. B cells are
responsible for tissue damage both by generating autoantibody-
producing cells and through other indirect mechanisms that may
break T cell tolerance. Understanding the factors that control the
survival of these pathological B cells is essential for elucidating the
pathogenesis of SLE (reviewed in [1,2]) and providing new targets
for SLE therapy (reviewed in [3,4]).
Our laboratory described a model of SLE in NIAID-pedigreed
non-inbred rabbits [5], based on earlier reports of James et al. [6]
that Multiple Antigen Peptide (MAP-8) immunogens elicited
lupus-like autoantibody responses. Their immunogen carried eight
copies of a peptide sequence derived from EBV EBNA1 protein
with sequence similarity to spliceosomal SmB/B9 protein Smith
(Sm) autoantigen. We confirmed their observation of autoantibody
responses following immunization and boosting with the same
peptide antigen and extended the work by immunizing with a
peptide from rabbit N-methyl-D-aspartate receptor NR2b (GR)
[5]. Cross reactivity of some anti-dsDNA autoantibodies with this
important receptor led to the suggestion that such cross reactive
anti-dsDNA antibodies play a role in neuropsychiatric manifesta-
tions of SLE [7,8]. All of the rabbits produced peptide-specific
antibodies and some also produced autoantibodies including anti-
dsDNA and anti-nuclear antibodies resembling those found in
human lupus patients. Two rabbits experienced seizures and one
developed nystagmus [5]. Heterogeneity of responses was
confirmed in further investigations by Puliyath et al [9] who used
the GR-MAP-8 peptide to immunize animals selectively bred from
earlier responder rabbits and provided evidence for genetic
contributions to autoantibody profiles in the rabbit model of SLE.
B-cell activating factor (BAFF; also termed BLyS, CD257,
TNFSF13B, TALL-1, and zTNF4) is a potent B cell survival factor
mainly expressed by myeloid cells and monocyte-derived dendritic
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are the BAFF receptor (BR3 also termed BAFF-R), the
transmembrane activator and calcium-modulator and cyclophilin
ligand interactor (TACI) and the B cell maturation antigen
(BCMA) (reviewed in [10]). TACI and BCMA bind both BAFF
and APRIL, another TNF ligand superfamily member. TACI
plays a role in negatively regulating mature B-cell homeostasis, but
TACI also plays a role in T-independent B-cell responses and class
switch recombination [11]. Recent reports suggest a role of BCMA
in controlling the lifespan of long-lived plasma cells [12]. The
numbers of mature B cells in secondary lymphoid organs, baseline
serum Ig levels and Ig responses to T-cell-dependent and -
independent antigens, are reduced in mice that cannot express
BAFF. Transgenic mice that over express BAFF develop
autoimmune disease resembling human lupus. Although T cells
are not required for the disease development in this mouse model,
innate immune signals through MyD88 are required for B cell
activation and production of autoantibodies [13].
Disease activity in human lupus patients has been reported to
correlate with serum BAFF levels (reviewed in [14]) and levels of
expression of BAFF, TACI and BR3 mRNA in PBMC of patients
with SLE were reported to be significantly elevated [15]. Clinical
trials targeting BAFF or its receptors are currently in progress [16];
(also reviewed in [17,18]). We chose to investigate BAFF and its
receptors in the rabbit SLE model because of their potential as
therapeutic targets for human SLE and the reported correlations of
disease activity with elevated serum BAFF protein [14] and BAFF
mRNA in PBMC [15]. On July 20, 2009, Human Genome
Sciences and GlaxoSmithKline announced that a placebo-con-
trolled BLISS-52 study of BENLYSTA
TM (belimumab, formerly
LymphoStat-BH) met the primary endpoint in the first of two Phase
3 trials in patients with serologically active SLE. See: http://www.
hgsi.com/latest/human-genome-sciences-and-glaxosmithkline-
announce-positive-phase-3-study-results-for-benl-2.html.
Before initiating this investigation of the role of BAFF and its
receptors in the rabbit model of SLE, we first studied expression
and localization rabbit BAFF and its specific high affinity receptor
BR3 in cells and tissues of the normal rabbit immune system [19].
We found that mRNA for both BAFF and BR3 was detectable in
normal rabbit peripheral blood mononuclear cells (PBMC). BAFF
message was detectable in CD14
+ macrophage/monocyte popu-
lations as well as some CD14
2 cell populations from peripheral
blood and spleen. We found high levels of mRNA for BR3 in
normal unstimulated IgM
+ B cells but they did not have detectable
BAFF message. Since surface BAFF was detected by flow
cytometry and immunohistochemical staining even though no
mRNA was detected, we suggested that soluble BAFF was
probably bound to BAFF receptors on IgM
+ B cells. We also
detected BAFF by immunohistochemical studies of developing
neonatal rabbit appendix and suggested that BAFF could play a
role in early stages of normal rabbit B-cell development [19].
Based on this initial groundwork, we set out to investigate BAFF
and its receptors during B-cell activation and autoantibody
production in rabbits derived from selective breeding to develop
a reproducible rabbit model of SLE. Flow cytometry was used to
detect BAFF, BR3 and TACI on PBMC prior to and after
immunization and boosting in order to seek associations of levels
of BAFF, BR3 and TACI with autoantibodies detected in serum
and hematological changes in blood. Quantitative PCR was used
to detect expression of BAFF and BR3 in PBMC prior to and after
immunization and boosting. In addition, b2-microglobulin (B2M)
mRNA expression was measured because it was found in earlier
studies to be elevated in expression in some lupus rabbits (Rai et al.
ms in preparation). Increased levels of B2M reflect elevated levels
of class I MHC molecules in activated PBMC. This study
broadens our knowledge of the expression of this important
member of the TNF superfamily in a non-inbred pedigreed rabbit
model of SLE where BAFF may specifically regulate B-
lymphocyte proliferation and survival.
Materials and Methods
Animals
The animal studies described here were reviewed and approved
by the animal care and use committees of NIAID/National
Institutes of Health, Bethesda, MD (animal study protocol LI-6)
and of the Spring Valley Laboratories (Woodbine, MD), where the
NIAID allotype-defined rabbit colony was housed. Rabbits of the
experimental group were relatives and descendants bred and
developed from the previous lupus experimental groups, based on
autoantibody responses. The animals’ designations, sexes, ages at
the start of the experiment, immunoglobulin allotypes including
VHa encoded at the Igh locus and Ckb encoded at the light chain
(Ck1) locus [20] are summarized in Table 1. The rabbits were
divided into four groups (A, B, C, and D) to allow handling of
blood for preparation of PBMC for FACS and mRNA isolation.
One control rabbit (CF) in group C died and was not replaced.
Pedigree analysis
Breeding information and experimental records on the breeding
colony were entered into a custom designed 4
th Dimension
relational database (Tiller systems, Brunswick, MD). Information
Table 1. Immunized rabbits, sexes, Ig allotypes and ages.
Group Rabbit ID Rabbit no. Sex Allotype Age (In months)
A GR72 UA345-5 F a2R3/2R3, b4/9k 13.5
GR73 UA269-3 F a1/1, b4/5 8.8
BB74 6YY328-4 M a1/1, b5/9 24.9
BB75 2YY125-6 M a1/2, b9k/9k 18.2
CF1 6YY328-3 M a1/1, b5/9 24.9
CF2 1UA161-1 M a1/1, b9/9 7.4
B GR76 2YY119-9 F a1/1, b9/9 18.1
GR77 UA269-1 M a1/1, b4/5 8.8
BB78 YY118-6 M a1/1, b9/9 18.0
BB79 1UA161-2 M a1/1, b9/9 7.4
CF3 1YY125-4 M a2/2, b4/9k 18.2
CF4 2YY125-4 M a2/2, b5/9k 18.2
C GR80 XA345-1 F a1/2, b9/9k 6.3
GR81 2UA14-2 F a1/1, b5/9 7.4
BB82 XA346-2 M a1/1, b9/9 6.3
BB83 2UA14-3 F a1/1, b5/9k 7.4
CF5 XA345-2 F a1/2, b9/9k 6.3
D GR84 XA234-6 F a1/2, b5/9 6.3
GR85 XA346-1 M a1/1, b9/9 8.9
BB86 XA234-2 M a1/2, b5/9 5.3
BB87 3XA203-2 M a1/ali, b5/9 4.2
CF6 2XA344-2 F a1/1, b9/9 8.8
CF7 1XA344-1 M a1/1, b9/9 8.8
doi:10.1371/journal.pone.0008494.t001
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of pedigrees (Jurek Software, Cottage Grove WI).
Antigens
The peptide sequence (DEWDYGLP) from the extracellular
domain of rabbit neuronal postsynaptic glutamate receptor N-
methyl-D-aspartate (NMDA) NR2b chain (peptide GR) was
synthesized on a multiple antigen-branched polylysine (multiple
antigen peptide) (MAP) backbone (BB). BB-MAP-8 without
peptide was synthesized as control immunogen. In addition,
adjuvant control rabbits (CF) received initial Complete Freund’s
Adjuvant (CFA) followed by boosts with Incomplete Freund’s
Adjuvant (IFA) emulsified with the same diluent used for the
antigens. All synthesized structures were analyzed by HPLC
(National Institutes of Health Peptide Synthesis and Analysis Unit,
Research Technology Branch, Rockville, MD).
Immunization
Each rabbit received initial subcutaneous (s.c.) injection of either
GR-MAP-8 (GR rabbits), control BB (BB rabbits) (0.5 mg/0.5 ml
in borate-buffered saline pH 8.0 (BBS), emulsified with 0.5 ml of
CFA), or control borate buffered saline, pH 8.0 (BBS) (0.5 ml of
BBS, with 0.5 ml of complete Freund’s adjuvant (CFA) (CF
rabbits). Rabbits received either 3 or 5 boosts given s.c. at 3-wk
intervals with the same antigen concentration or BBS) emulsified
with incomplete Freund’s adjuvant (IFA). After the final boost in
IFA, rabbits were injected intravenously (i.v.) 3 weeks later with
the same antigen concentration or BBS. Sera and heparinized
whole blood cells were collected immediately before immunization
(pre-immune) and 1 wk after each boost (post-boost). Sera were
aliquoted and stored at 220uC for assay. A sample of whole blood
was collected for complete blood cell and chemistry analysis, and
the remaining blood used for PBMC isolation for flow cytometry
analysis and mRNA. Blood for chemistry, hematology and PBMC
for mRNA analyses was collected a week later, and rabbits
euthanized 7 or 8 days after the final i.v. boost.
Clinical assessment
The rabbits were regularly monitored for clinical signs of disease
and subjected to periodic health examinations. Whole blood and
sera collected after boosts were sent to a veterinary diagnostic
laboratory (Antech Diagnostics) for complete blood counts and
chemistry panels as previously described [5,9].
ELISA for anti-peptide antibodies, anti-dsDNA and
autoantibodies to nuclear antigens
Serum antibody responses to the GR-MAP-8 and control
immunogens were measured by standard solid-phase ELISA.
Polystyrene 96-well plates (Corning; catalog no. 3590) were coated
with 50 ml/well of GR-MAP-8 at 10 mg/ml in bicarbonate buffer
(pH 9.6) and incubated overnight at 4uC. Plates were washed
three times with PBS (pH 7.2) containing 0.1% Tween 20 and
blocked with 100 ml of blocking solution for 1 h at 37uC (Quality
Biologicals). Wells were then incubated 1 h at 37uC with 50 ml/
well of 1/1024-diluted sera, washed five times, incubated for 1 h at
37uC with 50 ml of a 1/2000 dilution (0.4 ng/ml) of affinity-
purified HRP-conjugated goat anti-rabbit IgG (H + L) secondary
antibody (Jackson ImmunoResearch Laboratories), developed
with 3,39, 5,59-tetramethylbenzidine (TMB) (INOVA Diagnostics),
and the resulting OD read at 450 nm. Commercially available
human diagnostic kits (INOVA Diagnostics) were used to assay
serum antibodies to calf thymus dsDNA and autoantibodies to
nuclear antigens (ANA), and components (Sm and RNP) as
previously described [9]. Briefly, 100 ml of rabbit sera diluted 1/41
in the proprietary sample diluents were added to antigen-coated
wells and incubated for 30 min at RT. Wells were then washed,
incubated for 30 min at RT with 1/8000 diluted HRP-conjugated
goat anti-rabbit IgG Fc (Jackson ImmunoResearch Laboratories),
and developed with TMB for reading OD at 450 nm.
Antibodies and reagents for flow cytometry
Surface staining for BAFF was determined using biotin-
conjugated goat anti-human BAFF polyclonal antibody that cross-
reacts with rabbit BAFF; staining for TACI used biotin-conjugated
goat anti-human TACI polyclonal antibody that cross-reacts with
rabbit TACI (Antigenix, America, Inc.). Surface staining of BR3 was
detected using purified goat anti-human BR3 antibody that is cross-
reactive with rabbit BR3 (R&D systems) [19]. Also used were FITC-
labeled mouse anti-rabbit CD14 (clone K4) (Antigenix, America,
Inc.), FITC-labeled goat anti-rabbit IgM (Southern Biotechnology
Associates), biotin-labeled donkey anti-goat IgG, biotin-labeled goat
IgG,normalgoatIgG(JacksonImmunoResearchLaboratories,Inc),
and FITC-labeled mouse IgG2a (BD Pharmingen). Biotinylated
antibodies were visualized by PE-conjugated streptavidin (Jackson
ImmunoResearch Laboratories, Inc).
Detection of anti-nuclear antibodies (ANA) by indirect
immunofluorescence
Commercially available slides coated with fixed HEp-2 cells
(Antibodies, Inc.) were incubated with rabbit antisera diluted 1/20
in 5% goat serum (Jackson ImmunoResearch Laboratories) for
30 min at room temperature (RT). ANA binding was detected by
fluorescence microscopy following 30-min incubation at RT with
12.5 ng/ml FITC-goat anti-rabbit IgG Fc (Southern Biotechnol-
ogy Associates). Secondary antibody against IgG was selected to
avoid unwanted background fluorescence and positive results of
doubtful clinical importance. Fluorescent binding patterns were
compared with pictures in von Muhlen and Tan [21] and with
reference pictures provided with the Antibodies, Inc. kit.
Cell isolation
Viable PBMC were isolated from heparinized blood by density
gradient centrifugation on Lympholyte-Mammal (Cedarlane
Laboratories Limited). This permitted recovery of lymphocytes
and monocytes but eliminated most red cells and granulocytes.
After isolation, cells were immediately placed on ice for flow
cytometry assays or placed into TRIzol
TM reagent (Invitrogen) for
RNA isolation.
Flow cytometry
Purified PBMCs were stained using standard flow cytometric
methods. Briefly, cells were incubated on ice for 40 min with
primary antibody before washing twice with cold PBS containing
1% FCS, then subsequent incubation with various secondary
reagents or secondary antibodies [19]. For BR3 detection, a
biotinylated donkey anti-goat IgG was used as secondary antibody.
Biotinylated antibodies were visualized by PE-conjugated strepta-
vidin (Jackson ImmunoResearch Laboratories, Inc). After washing,
cells were analyzed using a FACS-Calibur flow cytometer (BD
Pharmingen) and FlowJo analytical software (Tree Star). Cells
were gated on side scatter6forward scatter (SSC6FSC) profiles to
include both small and large lymphocytes, as well as monocytes
but exclude red blood cells and granulocytes; dead cells were
excluded by propidium iodide staining. Rabbit IgM
+ B cells were
detected by FITC-conjugated goat anti-rabbit IgM (Southern
Biotechnology Associates).
Rabbit SLE, BAFF and Receptors
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mRNA
Viable PBMC isolated from heparinized blood by density
gradient centrifugation on Lympholyte-Mammal (Cedarlane
Laboratories Limited) were immediately placed in TRIzol reagent
after isolation, homogenized and filtered with Qiashredder column
(Qiagen). Total RNA was isolated by RNeasy spin column
(Qiagen) and precipitated with ethanol. First-stand cDNA was
synthesized using the SuperScript.
First-strand synthesis kit (Invitrogen). Quantitative PCR to
determine the relative expression levels of BAFF, BR3 and other
mRNAs was performed on 9700HT Sequence Detection System
(Applied Biosystems). Synthesized cDNA from isolated PBMCs
was directly used as template for real-time PCR by using TaqMan
26PCR Master Mix Reagents Kit (Applied Biosystems). Relative
expression levels of an additional mRNA for rabbit b2-
microglobulin (B2M) found in earlier studies (Rai et al. ms in
preparation) to be elevated in expression in some lupus rabbits was
also measured. The primers, probes and PCR conditions used are
shown in Table 2. Each sample from three independent
experiments was run in duplicate. The unit number showing
relative mRNA levels in each sample was determined as a value of
mRNA normalized against peptidylprolyl isomerase A (PPIA).
Previous studies showed uniform expression of PPIA in total
WBCs from both normal and treated rabbits (Rai et al. ms in
preparation).
Statistical analysis
Student’s t test, Pearson’s correlation analysis and ANOVA
procedures were performed using SAS v8.0, JMP-7 and Prism
software to examine associations of BAFF, BR3, and TACI
measurements with antibody responses and hematological
data.
Results
Clinical findings and leukocyte responses
As in the previously studied rabbits that developed autoanti-
bodies [5,9], no evidence of kidney damage or pathology was seen
in the present group. However, as observed in the 5
th group [9],
hematological profiles suggested development of chronic inflam-
matory responses. Supporting online Table S1 summarizes
observed changes in total White Blood Cell (WBC), Monocyte,
Neutrophil, Eosinophil and Basophil counts after immunization.
Values in bold face are above the normal reference range shown in
the footnote to the table. With the exception of two Freund’s
immunized control rabbits (CF3 and CF4), rabbits developed
higher WBC counts by the third or fifth boost with many above
the normal reference range. Total WBC counts were elevated
above the normal reference range (4–10610
3/ml) in two
littermates (BB 74 and CF1) prior to immunization (pre) and
became further elevated after the 3
rd boost. The mean WBC
counts (610
3/ml) in all rabbits prior to immunization were 7.30+/
21.71 (SD) and rose to 11.40+/23.17 and 11.60+/23.12 after
the third and fifth boosts. Lymphocyte numbers generally
remained within the normal reference range (1.2–7610
3/ml) but
there were elevations in neutrophils (2.0+/20.79 in pre and 5.9+/
22.23, 5.1, +/22.02 after 3
rd and 5
th boosts) and monocytes
(0.26+/20.13 in pre and 0.65+/20.29 and 0.57+/20.25 after 3
rd
and 5
th boosts). Some eosinophil and basophil counts also
increased with a few shown in bold face in Table S1 exceeding
the normal reference ranges (0–0.10;0–0.50). These results
confirm and extend those previously reported [9] that raised the
possibility that among these selectively bred pedigreed animals,
CFA followed by IFA could generate the elevated leukocyte
response we found after immunization with GR-MAP-8 or the
branched BB-MAP-8 without additional peptide. The CF group
was added to the present study because we had not previously
investigated the role of CFA followed by IFA. We conclude that in
some of these selectively bred rabbits, elevated leukocyte response
typical of chronic inflammatory responses but not of human SLE
can occur due to the immunization protocol using CFA and IFA.
Anti-peptide and autoantibody responses
Table 3 contains primary data obtained by Q-PCR, ELISA and
ANA indirect immunofluorescence. Figure 1 summarizes pre-
immune and post-immune measurements of anti-peptide and anti-
dsDNA responses. In panels A and B, the pre-immune OD
450 nm values are shown in light blue and the responses after each
boost are shown in distinct colors. The low pre-immune values
were not subtracted from the post-immune values shown. Four of
the eight rabbits that were immunized with GR-MAP-8 developed
high anti-dsDNA by the third boost and four developed lower
responses (Figure 1C). A marked increase in anti-dsDNA was
measured in one animal that received MAP-8 backbone (BB86)
starting after the second boost, and one animal that received only
CFA followed by IFA (CF5) developed anti-dsDNA after the 5
th
boost.
Figure 2 shows that in contrast to anti-dsDNA responses, most
pre-immune sera assayed by ELISA already had background anti-
nuclear antibodies (ANA), anti-Sm and anti-RNP. All post-
immunization responses are plotted as DOD; the OD at 450 in
post-boost sera minus the OD at 450 in pre-immune sera (these
background values are shown separately in light blue). The same
animal (CF5) that developed anti-dsDNA after the 5
th boost also
developed an elevated positive anti-RNP response at that time. As
observed in earlier studies [5,9], ANA ELISA values increased in
most of the peptide immunized (GR) and backbone immunized
Table 2. Primers and probes for quantitation of mRNA by Q-
PCR for rabbit BAFF, BR3, PPIA control and b2 microglobulin
(B2M).
A. BAFF and BR3
a
BAFF forward 59 TGGTCAAAGAAACTCGGGTACTT 39
BAFF reverse 59 TGTTTTGAATGCAACGGAACA 39
BAFF probe 59 TCATATACGGTCAGGTCTT 39
BR3 forward 59 CGGGACGGAGACCAGGA 39
BR3 reverse 59 TGAGTTGGGAGCTGTGGCA 39
BR3 probe 59 AGTCCCTGGATGATGTCA 39
B. PPIA control
a
PPIA forward 59 CAACACAAATGGCTCCCAGTT 39
PPIA reverse 59 CATGGCTTCCACAATGCTCAT 39
PPIA probe 59 ATCTGCACTGCCAAGAC 39
C. B2M
a
B2M forward 59 TTGTTCCCCTGCCTGGAGT 39
B2M reverse 59TGGATGACGAGAGTACACTTGAACAT 39
B2M probe 59 CCAGCGTGCTCCG 39
aThe total volume of PCR reaction was 25 ml and the PCR conditions were as
follows: 50uC for 2 min, 95uC for 10 min, followed by 40 cycles of 95uC, 15 s for
denaturation and 60uC, 1 min for annealing and extension.
doi:10.1371/journal.pone.0008494.t002
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PLoS ONE | www.plosone.org 5 December 2009 | Volume 4 | Issue 12 | e8494(BB) control animals. Increases were also observed in four of the
seven CF adjuvant control animals. The contribution of adjuvant
treatment to autoantibody responses in this model was raised and
discussed in our previous paper [9]. Not only do elevated leukocyte
levels typical of chronic inflammatory responses occur due to the
immunization protocol using CFA and IFA (Table S1), but in
some of these selectively bred rabbits, whether exposed to peptide
GR, BB or CF alone, also produce ANA measured by both ELISA
and indirect immunofluorescence on HEp-2 cells (Figure 3 and
Table 3).
Figure 3 shows examples of test results for ANA detected by
indirect immunofluorescence on HEp-2 cells, in pre-immune and
post immune sera from litter-mate pairs representing four GR- two
BB- and two CF-immunized animals. Fluorescent binding patterns
were compared with pictures in [21] and with reference pictures
provided with the Antibodies, Inc. kit. Patterns shown in Figure 3
include homogeneous and peripheral nuclear, speckled, cytoplas-
mic, and nucleolar staining. We previously noted that ANA
indirect immunofluorescent staining patterns using sera from BB
immunized animals generally differed from those of GR
immunized animals, but in those studies the contribution of
adjuvant alone was not evaluated [5,9]. A retrospective study of
690 sera from 58 SLE patients and1187 sera from other patient
controls, reported that sera of SLE patients with high levels of anti-
dsDNA did not necessarily exhibit homogeneous staining but were
also found associated with speckled or nucleolar patterns [22].
They reported that patterns of ANA staining with sera of SLE
patients were typical for a particular patient [22]. We therefore
chose examples of results of ANA indirect immunofluorescence
tests of pre-immune and post immune sera from pairs of
littermates (Figure 3). Littermates UA269-3 and -1 were both
GR immunized (GR73 and GR77). The peripheral nuclear
Figure 1. ELISA measurements of anti-peptide and anti-dsDNA responses. In panels A (anti-peptide B) and B (anti-dsDNA), the pre-immune
OD 450 nm values are shown in light blue and the responses after each boost are shown in distinct colors. The low pre-immune values were not
subtracted from the post-immune values shown. C. Mean responses of GR-, BB- and CF- immunized rabbits showing high and low anti-dsDNA
responders (ds) among GR-MAP-8 immunized rabbits. Each symbol represents an individual rabbit serum tested prior to immunization (Pre ds), after
the 3
rd,5
th and intravenous (iv) boosts.
doi:10.1371/journal.pone.0008494.g001
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PLoS ONE | www.plosone.org 6 December 2009 | Volume 4 | Issue 12 | e8494staining patterns of both appeared similar at 3
rd boost and GR73
remained similar at 5
th boost. However staining intensity with 5
th
boost serum of GR77 increased and the pattern appeared
speckled. GR85 and BB82 (XA346-1 and 2) exhibited distinct
staining patterns with GR85 showing some cytoplasmic and
peripheral nuclear staining not seen in its BB-immunized BB82;
littermates GR80 and CF5 (XA345-1 and -2) both exhibited only
minimal ANA staining although CF5 that produced some anti-
dsDNA after the fifth boost also developed increased ANA
fluorescence with some nucleolar staining. Finally, background
pre-immune ANA peripheral nuclear staining with sera of
littermates BB75 and CF4 (2YA125-6 and -4) remained the same
although it became slightly more intense in BB75 after the 3
rd
boost. As with human SLE patients, we found IFA patterns
reflecting responses to one or more autoantigens in different
rabbits.
Analyses of BAFF, BR3 and TACI by flow cytometry
The set of data collected is tabulated as supplemental online
information (Table S2). Examples of flow cytometry (FACS)
profiles are shown in Figure 4. In the table, ‘‘total cells’’ refers to
all live cells in the lymphocyte monocyte gate (Figure 4A left
panel). Cells were gated on side scatter6forward scatter
(SSC6FSC) profiles to include both small and large lymphocytes
as well as monocytes but to exclude red blood cells and
granulocytes. We analyzed CD14
+ cells because in our previous
report on BAFF and BR3 in normal rabbits [19], we showed that
in PBMC, it was the CD14
+ cells that expressed high levels of
BAFF mRNA. In the example shown in Figure 4A, right panel,
IgM staining of the gated cells from pre-immune PBMC of rabbit
GR84 shows that two positive cell populations were observed
(IgM
high and IgM
low). In Table S2, percentages and median
fluorescent intensities (MFI) shown are of IgM
+ (IgM
high and
IgM
low) cells because it is not always possible to clearly delineate
the two populations. Percentages of cells positive by FACS and
their median fluorescence intensities shown permit comparisons of
staining results on pre-immune samples (Pre) with results on
samples after 3rd and 5th boosts. Colors in Table S2 highlight
values that increased (orange), or decreased (blue), compared to
pre-immune values. In Figure 4B, the histograms show the staining
of total PBMC from pre-immune and post 3
rd boost of GR-
immunized anti-dsDNA high responder (GR72) and low respond-
er (GR84) for BAFF or BR3 and the control antibody. In both
rabbits percentages of BAFF and BR3 positive cells decreased or
remained essentially unchanged (Table S2). Figure 4C (upper two
rows) shows representative results of double staining for BAFF or
TACI on the surface of IgM
+ cells from PBMC and for BAFF,
TACI or BR3 on CD14
+ cells from the same high (GR72) and low
(GR84) responders (lower three rows). Percentages of cells in
individual quadrants are indicated. The percentages of total BR3
+
PBMC and BR3
+ CD14
+ cells in PBMC detected by FACS
increased in two of four high anti-dsDNA responder animals
(GR77 and GR80). Median fluorescence intensities (MFI) of
staining, although very low, also increased on cells of the same two
animals (Table S2).
In order to provide an overview of FACS analyses of BAFF,
TACI and BR3 on total PBMC, or CD14
+ cell populations from
PBMC (Table S2 and Figure 4) and results of measurements of
BAFF and BR3 mRNA in total PBMC by Q-PCR (Table 3),
Figure 5 shows results pre-immunization and after the third boost
grouped according to high and low anti-dsDNA responses of GR-
immunized compared with BB- and CF- immunized animals.
Percentages of BAFF positive cells and MFI generally remained
unchanged or decreased in all the immunized groups but a
decrease was most consistent in the high anti-dsDNA responder
animals. Another consistent change observed by FACS staining
was in TACI. Percentages and MFI of TACI staining of
total PBMC decreased in most of the immunized rabbits in all
groups.
Q-PCR analyses of BAFF, BR3 and B2M expression
BR3 mRNA levels decreased after the third boost in six of eight
GR-immunized rabbits (Table 3 and Figure 5). BR3 mRNA levels
in BB and CF immunized also decreased slightly in most animals.
The levels of BAFF mRNA in PBMC pre-immunization and in
Figure 2. ELISA measurements of other autoantibody respons-
es. The pre-immune OD 450 nm values found by ELISA for anti-nuclear
antibodies (ANA), anti-Sm and anti-RNP are shown separately in light
blue because of the high levels of antibodies in some rabbits prior to
immunization. All post-immunization responses are given as DOD (the
OD 450 in post-boost sera minus the OD 450 in pre-immune sera).
doi:10.1371/journal.pone.0008494.g002
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PLoS ONE | www.plosone.org 7 December 2009 | Volume 4 | Issue 12 | e8494cells collected after the 3rd boost generally remained low and
unchanged (Table 3 and Figure 5). Two rabbits (GR84 and 85)
that exhibited low anti-dsDNA responses had increased BAFF
mRNA after the 3rd boost. In each group, increased levels of
mRNA encoding B2M were found in half of the immunized
rabbits after the third or fifth boost (Table 3).
Figure 3. ANA indirect immunofluorescence. Examples of immunofluorescent staining results using pre and post-immune sera from pairs of
littermates selected from GR-peptide, BB control and adjuvant control (CF) animals.
doi:10.1371/journal.pone.0008494.g003
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PLoS ONE | www.plosone.org 8 December 2009 | Volume 4 | Issue 12 | e8494Figure 5 provides an overview that summarizes results of
measurements of pre-immune (Pre) and post boost 3 (3
rd) BAFF
and BR3 mRNA in total PBMC by Q-PCR (Table 3), FACS
analyses of percentages of cells and median fluorescence intensities
(MFI) of BAFF, TACI and BR3 on total PBMC, or CD14
+ cell
populations from PBMC (Table S2 and Figure 4). In the GR high
anti-dsDNA responders, three way ANOVA with repeated
measures indicated significant decreases in percentages and
MFI of BAFF
+ cells among total PBMC (p 0.015 and 0.0002
respectively) as well as MFI on CD14
+ cells (p 0.012). Decreased
percentage of BAFF
+ CD14
+ cells was near significance (p 0.06).
Decreased percentages of TACI
+ cells among PBMC
were significant or near significant in GR low, BB and CF groups
(p 0.03, 0.013, 0.09 respectively); decreased TACI MFI
were also near significant or significant (p 0.06, 0.07 and 0.03
respectively).
Summary of autoantibody responses and pedigree
A pedigree showing summaries of the responses of selected
animals from five previous immunization groups 1–5 was
published [9]. Figure 6 shows the present group 6 added on to
ancestors reported previously [5,9] and summarizes their autoan-
tibody responses. Responders such as GR72, 73, 76,77 and 85 can
trace relationships in their pedigree back to key founders including
rabbits that exhibited seizures (SM1, GR9), and high responder
males including SM13 and SM15 [5]. The trend toward more
consistent autoantibody production observed in group 5 [9],
continues here. Immunization of relatives of GR peptide
immunized animals with Freund’s complete followed by incom-
plete adjuvant (CF group) or with backbone alone (BB group) did
elicit some production of autoantibodies. This suggests that in this
line of rabbits, some have developed susceptibility to development
of autoantibodies regardless of the immunogen. However,
inclusion of the eight copies of GR peptide on the backbone of
branched polylysine (GR-MAP-8) more consistently elicited
autoantibody production.
Discussion
The rabbit has long been a model for human autoimmune and
infectious diseases. It is now increasing in importance because the
genetics of the immune system is well defined, the entire rabbit
genome has been sequenced and a high quality draft assembly (76
coverage) was completed in April 2009 (GenBank Accession
Number AAGW02000000). The assembly of the 26 coverage
completed in 2005 plus the 76 trace archive already provided
useful information that has contributed to the present report and
the previous one that described expression and localization of
rabbit BAFF and its specific receptor BR3 in cells and tissues of
normal rabbits [19]. Human disease models developed in non-
inbred but genetically defined animals are better able to reflect the
complexities of those human diseases with familial patterns of
inheritance due to variants of genes at numerous loci with
potential to contribute to the disease phenotype. Systemic Lupus
Erythematosus and other autoimmune diseases are in this
category. Our model of SLE that elicits autoantibodies after
immunization with a peptide from the NMDA glutamate receptor,
can provide a means for development of further insights into
neuropsychiatric lupus, and pursuit of therapeutic targets.
Limitations were imposed upon the work presented here
because there are currently no rabbit-specific reagents for BAFF
and its receptors available. We therefore had to discover and
utilize cross-reactive antibodies. This decreased sensitivity of
analyses and quantitation by FACS. Fortunately, sequences of
Figure 4. Typical profiles from flow cytometry measurements.
A. PBMCs were gated based on forward and side scatter (FSCxSSC)
profiles (left panel). IgM
+ cells in peripheral blood can be divided into
IgM
high and IgM
low cell populations (right panel). B. Representative plots
from pre-immune (Pre) and post 3
rd boost (.3B) analyses of GR anti-
dsDNA high responder (GR72) and low responder (GR84) rabbits. The
histograms show the staining of total PBMC for BAFF and BR3 and the
control biotin-labeled normal goat IgG for BAFF normal goat IgG for
BR3 (shaded). C. Representative dot plots from GR anti-dsDNA high
responder (GR72) and low responder (GR84). The plots showed the
staining of BAFF and TACI on the surface of peripheral blood IgM
+ cells
and of BAFF, TACI and BR3 on CD14
+ cells.
doi:10.1371/journal.pone.0008494.g004
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PLoS ONE | www.plosone.org 9 December 2009 | Volume 4 | Issue 12 | e8494Figure 5. Summary of BAFF and BR3 mRNA expression by Q-PCR, BAFF, BR3, and TACI expression by FACS. Plotted are means and
SEM of results comparing high and low anti-dsDNA responders of GR- immunized with BB- and CF-immunized rabbits (anti-dsDNA OD at 450 nm as
determined by ELISA). This overview summarizes results of measurements of pre-immune (Pre) and post boost 3 (3
rd) BAFF and BR3 mRNA in total
PBMC by Q-PCR [in Table 3, the unit number showing relative mRNA levels in each sample was determined as a value of mRNA normalized against
peptidylprolyl isomerase A (PPIA)]. The figure also shows means and SEM of results of FACS analyses of percentages of cells and median fluorescence
intensities (MFI) of BAFF, TACI and BR3 (Table S2 and Figure 4) on total PBMC, or CD14
+ cell populations from PBMC (the bars are not stacked). In the
GR high anti-dsDNA responders, three way ANOVA with repeated measures indicated significant decreases in percentages and MFI of BAFF
+ cells
among total PBMC (p 0.015 and 0.0002 respectively) as well as MFI on CD14
+ cells (p 0.012). Decreased percentage of BAFF
+ CD14
+ cells was near
significance (p 0.06). Decreased percentages of TACI
+ cells among PBMC were significant or near significant in GR low, BB and CF groups (p 0.03,
0.013, 0.09 respectively); decreased TACI MFI were also near significant or significant (0.06, 0.07 and 0.03 respectively).
doi:10.1371/journal.pone.0008494.g005
Rabbit SLE, BAFF and Receptors
PLoS ONE | www.plosone.org 10 December 2009 | Volume 4 | Issue 12 | e8494rabbit BAFF, BR3 and B2M allowed us to conduct successful
quantitative PCR measurements of mRNA levels in PBMC.
Just as there are known differences between mice and humans in
details of the effects of BAFF and its receptors on B-cell subsets, and
their regulated development, there are likely to be additional
species-specific aspects of the complex regulation of rabbit B- cell
development including involvement of BAFF, BR3, TACI, APRIL
and BCMA. Although BAFF is essential for development and
maintenance of most B-cells, CD5-positive B-1 cells develop in mice
lacking BAFF or BR3 [23,24]. However, it has more recently been
observed that BAFF does stimulate mouse B1 B cells (25). Although
only a small proportion of mouse and human B cells are CD5
+,i n
rabbits the majority of B cells as well as T cells are CD5
+ [26,27].
However, rabbit CD5
+ B cells are not functional equivalents of
murine B-1 B-cells and some features of rabbit CD5
+ B cells differ
from human and mouse [28]. It also appears that the CD5
associated with rabbit B- and T-lymphocytes differs [29].
Immunohistochemical studies of spleens from normal [19] and
immunized rabbits (data not shown) detected BAFF staining on
large CD4+ T cells IgM
+ B cells, but we did not detect differences in
CD5 staining in immunized compared to normal rabbits.
Another major limitation has been our inability to detect serum
BAFF with currently available cross-reacting reagents. We
previously demonstrated that BAFF mRNA was not detectable
in IgM
+ B cells from normal rabbit PBL suggesting that BAFF
detected by flow cytometry on the B cells was probably soluble
BAFF bound to BAFF receptors [19]. Normal human peripheral
blood B cells and tonsillar naive and memory B cells were found to
have pre-bound BAFF although tonsillar activated B cells did not
[30]. Higher occupancy of BR3 by BAFF was reported to correlate
with disease activity in man [31]. The BAFF staining on B cells in
peripheral blood and spleens from rabbits producing autoanti-
bodies may either reflect BAFF produced by the B cells of rabbits
with lupus-like autoantibodies or again be bound through BAFF
receptors on B cells. In those GR high anti-dsDNA rabbits in
which BAFF detected on PBMC decreased significantly, perhaps
less pre-bound BAFF was present on BR3 or other receptors.
Although surface expression of BAFF, BR3 and TACI detected by
flow cytometry decreased on PBMC after immunization and
boosting in most animals, two GR high anti-dsDNA rabbits
(GR76 and GR77) developed higher percentages of BAFF
+
CD14
+, BR3
+ CD14
+, as wells as BR3
+ cells among total PBMC.
Figure 6. Pedigree and summary of autoantibody responses. An overview of key ancestors, autoantibody responses, and the relationship of
males (large squares) and females (large circles) in the current (group 6) to rabbits in 5 earlier groups is shown. Colors in the four quadrants indicate
postimmunization elevations of levels of anti-dsDNA (blue, upper left), anti-Sm and/or anti-RNP (yellow, lower left), ANA by IFA (red upper right) and
ANA by ELISA (brown diagonal lines, lower right). For the previous group 5 [9] and present group 6 animals, darker colors indicate high autoantibody
responses (Tables 3).
doi:10.1371/journal.pone.0008494.g006
Rabbit SLE, BAFF and Receptors
PLoS ONE | www.plosone.org 11 December 2009 | Volume 4 | Issue 12 | e8494Conceivably occupancy of BR3 by soluble BAFF may block access
to BR3 by anti-BR3 antibody on large activated PBMC. CD14 is
found on the surface of peripheral blood monocytes and
macrophages, acts as a co-receptor for detection of bacterial
lipopolysaccharide (LPS), and mediates innate immune responses
to LPS leading to cytokine secretion and inflammatory responses
[32]. Our FACS data also showed that CD14 is also found on
large IgM
low rabbit B cells (data not shown).
We observed consistently lower TACI percentages and MFI on
total PBMC by FACS in most injected animal after their third
boosts. It could be that in the rabbit, TACI also plays a negative
regulatory role as observed in mice [33]. Other functions of TACI
in mice include regulation of the T-independent humoral
responses [34]. More complex roles for TACI in human
peripheral B-cell development, class switch recombination and
terminal differentiation were suggested by discoveries of TACI
deficient patients [35, and reviewed in 36]. Since TACI appears to
function like a negative regulator of B cells in mice and humans, in
this rabbit model of SLE, perhaps the decrease in TACI allows the
autoreactive B cells to escape selection/regulation and thereby,
produce auto-antibodies.
We were unable to address roles for potential rabbit homologs
of APRIL and BCMA. APRIL is the TNF family member most
closely related to BAFF. APRIL also binds TACI and BCMA and
is expressed by lymphoid cells and some tumor cells. Recently
Ingold et al [37] proposed that proteoglycans such as syndecan are
APRIL-specific receptors that bind APRIL, induce oligomeriza-
tion prior to the interaction of APRIL with TACI or BCMA to
initiate survival signals. Additional complexities are likely due to
different forms (alternatively spliced, trimer, 60-mer of BAFF plus
heteromeric forms of BAFF with APRIL) interacting with the
different receptors for BAFF. Bossen et al [38] reported that
although BAFF-R and TACI can provide B cells with similar
signals, only BAFF-R, but not TACI, can respond to soluble BAFF
trimer. They found that BAFF 60-mer was more than 100-
fold more active than BAFF 3-mer for the activation of
multimerization-dependent signals.
It is hoped that the limitations we encountered in working with
few available reagents to detect cells and proteins of the rabbit
immune system will diminish and companies will produce more
rabbit-specific reagents because there is an increasing community
of researchers who use rabbits for research on autoimmune,
infectious, neurological, cardiovascular, ocular and other diseases.
Using the new NIH research portfolio online reporting tool
(RePORT) http://projectreporter.nih.gov, 424 current projects
match the search criteria: ‘‘Rabbit, Fiscal Year: Current Projects’’.
See also, ‘‘The Rabbit in Immunology & Infectious Disease
Research’’ at: http://www3.niaid.nih.gov/LabsAndResources/
resources/ri/.
The differences we have observed between individual rabbits
mirror similar heterogeneity of populations of lupus patients.
Large patient populations were required in order to detect some
correlations between BAFF expression, autoantibody production,
and disease status [14–16].
This study confirms and extends evidence for a genetic
contribution to autoantibody responses in the rabbit SLE model
we developed. In spite of the complexities of interactions of
multiple receptors and ligands in the BAFF system discussed
above, future gene expression analyses of cells and tissues from
rabbits with induced autoantibody production may reveal
dysregulated pathways that permit autoantibody-producing B
cells to survive.
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